NASDAQ:OPCH • US68404L2016
The current stock price of OPCH is 34.67 USD. In the past month the price decreased by -0.23%. In the past year, price increased by 10.2%.
ChartMill assigns a technical rating of 6 / 10 to OPCH. When comparing the yearly performance of all stocks, OPCH is one of the better performing stocks in the market, outperforming 74.65% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to OPCH. OPCH scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months OPCH reported a non-GAAP Earnings per Share(EPS) of 1.49. The EPS increased by 25.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.78% | ||
| ROA | 6.01% | ||
| ROE | 15.39% | ||
| Debt/Equity | 0.85 |
18 analysts have analysed OPCH and the average price target is 40.61 USD. This implies a price increase of 17.15% is expected in the next year compared to the current price of 34.67.
For the next year, analysts expect an EPS growth of 44.18% and a revenue growth 14.25% for OPCH
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 10.64 | 97.772B | ||
| CI | THE CIGNA GROUP | 9.43 | 77.65B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 97.51 | 24.095B | ||
| LH | LABCORP HOLDINGS INC | 16.09 | 24.032B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.91 | 23.285B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.861B | ||
| DVA | DAVITA INC | 10.91 | 9.89B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.24 | 7.225B | ||
| CHE | CHEMED CORP | 18.04 | 6.555B |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The company is headquartered in Bannockburn, Illinois and currently employs 6,015 full-time employees. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. The company provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. The company administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
OPTION CARE HEALTH INC
3000 Lakeside Dr, Suite 300N
Bannockburn ILLINOIS 60015 US
CEO: John C. Rademacher
Employees: 7052
Phone: 13129402443
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The company is headquartered in Bannockburn, Illinois and currently employs 6,015 full-time employees. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. The company provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. The company administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.
The current stock price of OPCH is 34.67 USD. The price increased by 4.59% in the last trading session.
OPCH does not pay a dividend.
OPCH has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
OPTION CARE HEALTH INC (OPCH) operates in the Health Care sector and the Health Care Providers & Services industry.
OPTION CARE HEALTH INC (OPCH) has a market capitalization of 5.50B USD. This makes OPCH a Mid Cap stock.